Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

Design Principles in the Beyond Rule of 5 Space

Автор: Drug Hunter

Загружено: 2024-07-12

Просмотров: 2855

Описание:

Modern drug discovery is now capable of targeting previously considered undruggable targets. The complexity of medicines is increasing, with many drug molecules and modalities violating at least one of Lipinski's Rule of 5 (Ro5) parameters. In the "beyond Rule of 5" (bRo5) space, unique design principles are essential. Optimizing permeability and lipophilicity is particularly challenging due to their typical anti-correlation.

In this Flash Talk, Henrik Moebitz discussed design principles in the bRo5 space. As a computational chemist, he is an expert in navigating bRo5 chemical space using physics-based computation. Henrik explained how an analysis revealed that 3D PSA and logP thresholds of oral Ro5 and bRo5 candidates coincide. He introduced neutral TPSA as a new parameter for lead optimization in bRo5 drug campaigns and demonstrated its optimization across four first-in-class campaigns, which led to clinical candidates or approved drugs. Notably, Henrik led the medicinal chemistry team that discovered the first-in-class WRN inhibitor, HRO761.

00:00 Introduction
02:25 Ice-breaker questions
10:49 Drug Hunter case study preview
13:00 Presentation
50:34 Q&A

Presented by Henrik Moebitz, Ph.D. Director- CADD, Global Discovery Chemistry with host Dennis Koester, Director of Industry Research and Relations Drug Hunter

Henrik trained as an organic chemist and completed his Ph.D. in biochemistry at the University of Freiburg. He furthered his studies in enzyme catalysis through postdoctoral training at UC Santa Barbara, focusing on the molecular mechanics of enzymes. In 2005, he joined the department for computer-aided drug discovery (CADD) at Novartis in Basel. Currently, he co-leads the Basel CADD group and oversees several medicinal chemistry projects. Henrik is the author of over 50 publications and patents, with a significant body of his recent work still awaiting publication.

Presented on July 11, 2024, as part of our Drug Hunter Flash Talk series.

Sign up for future sessions here: https://drughunter.com/flash-talk-ser...
Sign up for our free newsletter here: https://drughunter.com/newsletter-sig...

Design Principles in the Beyond Rule of 5 Space

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Not a Hypothesis: The Free Drug Principle

Not a Hypothesis: The Free Drug Principle

VC Biotech Investing and Company Creation 101

VC Biotech Investing and Company Creation 101

Reimagining Druggability using Chemoproteomic Platforms

Reimagining Druggability using Chemoproteomic Platforms

Analysis of Successful Hit-to-Clinical Candidate Pairs

Analysis of Successful Hit-to-Clinical Candidate Pairs

The History and Future of the Atmosphere: Historical Emissions Data and CMIP7 | CSER Webinar Series

The History and Future of the Atmosphere: Historical Emissions Data and CMIP7 | CSER Webinar Series

Лекция 12, концепция 08: Правило(а) Липинского 5

Лекция 12, концепция 08: Правило(а) Липинского 5

Targeting NLRP3: DFV890 and Beyond

Targeting NLRP3: DFV890 and Beyond

From Molecular Properties to Mechanistic ADME: A Guide to Scoring Success

From Molecular Properties to Mechanistic ADME: A Guide to Scoring Success

The Energy Storage Problem No One Explained Properly

The Energy Storage Problem No One Explained Properly

Brooks and Atkins Stohr on Trump's return and its impact on the country

Brooks and Atkins Stohr on Trump's return and its impact on the country

Lessons in LAI: Discovery of a Long-Acting Injectable TAK1 Inhibitor

Lessons in LAI: Discovery of a Long-Acting Injectable TAK1 Inhibitor

Patenting Strategies for Small Molecule Drugs

Patenting Strategies for Small Molecule Drugs

Precision Drug Delivery Systems | Steven Rosenzweig | TEDxCharleston

Precision Drug Delivery Systems | Steven Rosenzweig | TEDxCharleston

Introduction : Computational Structural Biology Lecture L01 by Bruce Donald, Duke University

Introduction : Computational Structural Biology Lecture L01 by Bruce Donald, Duke University

Как изменилась война за год?

Как изменилась война за год?

Discovery of Novel Cardiac Myosin Modulators Omecamtiv Mecarbil and Aficamten

Discovery of Novel Cardiac Myosin Modulators Omecamtiv Mecarbil and Aficamten

Tackling MedChem Bias One Functional Group at a Time

Tackling MedChem Bias One Functional Group at a Time

Process Development Strategies to Deliver Robust Manufacturing Processes

Process Development Strategies to Deliver Robust Manufacturing Processes

Introduction to AI in Drug Discovery

Introduction to AI in Drug Discovery

Merck - Impacting Life & Health With Science & Tech

Merck - Impacting Life & Health With Science & Tech

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]